Cancer Immunotherapy Guidelines Head and Neck Subcommittee

SITC Cancer Immunotherapy Guidelines (CIGs) are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key indicators to help practicing oncologists determine when and how to best use immunotherapy to treat their patients. These systematically developed recommendations promote enhanced clinical decisions concerning patient selection, toxicity management, clinical endpoints, and the sequencing or combination of therapies. The Head & Neck Subcommittee was developed to generate consensus statements specifically for cancers of the head and neck.

Chair

Robert L. Ferris, MD, PhD – UPMC Hillman Cancer Center